Nursing Care Plan (NCP) for Peptic Ulcer Disease (PUD)

Lesson Objective For Nursing Care Plan (NCP) for Peptic Ulcer Disease (PUD)

• Understanding of Peptic Ulcer Disease (PUD):
  • Define Peptic Ulcer Disease and differentiate between gastric and duodenal ulcers.
  • Comprehend the etiology and contributing factors leading to the development of PUD.
• Recognition of Signs and Symptoms:
  • Identify common clinical manifestations of PUD, including epigastric pain, nausea, vomiting, and gastrointestinal bleeding.
  • Recognize the variations in symptoms between gastric and duodenal ulcers.
• Diagnostic Procedures:
  • Understand the diagnostic procedures used to confirm the presence of peptic ulcers, such as endoscopy, barium contrast studies, and Helicobacter pylori testing.
• Pharmacological Interventions:
  • Explore the pharmacological treatments commonly used in managing PUD, including proton pump inhibitors (PPIs), H2-receptor antagonists, and antibiotics for H. pylori eradication.
• Lifestyle Modifications and Patient Education:
  • Discuss lifestyle modifications that promote ulcer healing, such as dietary changes, stress management, and avoidance of NSAIDs and alcohol.
  • Provide patient education on the importance of medication adherence, follow-up appointments, and recognizing and reporting worsening symptoms.

Pathophysiology of Peptic Ulcer Disease (PUD)

• Gastric Acid and Pepsin Secretion:
  • Peptic Ulcer Disease is characterized by an imbalance between aggressive factors, such as gastric acid and pepsin secretion, and protective factors, such as mucosal integrity.
  • Excessive production of gastric acid and pepsin can contribute to the erosion of the mucosal lining of the stomach or duodenum.
• Mucosal Defense Mechanisms:
  • The stomach and duodenum have protective mechanisms to resist the harmful effects of gastric acid.
  • Mucus production, bicarbonate secretion, and blood flow to the mucosa contribute to maintaining mucosal integrity.
• Breakdown of Mucosal Defense:
  • When there is an imbalance, such as increased acid secretion, reduced mucosal blood flow, or disruption of protective mechanisms, the mucosal lining may become compromised.
  • Erosions or ulcerations occur in the stomach or duodenum, leading to symptoms such as pain, discomfort, and, in severe cases, gastrointestinal bleeding.

Etiology (Causes) of Peptic Ulcer Disease (PUD)

• Helicobacter pylori Infection:
  • H. pylori is a common bacterium that infects the stomach lining and is a primary cause of peptic ulcers.
  • The bacterium weakens the mucosal defense, allowing gastric acid to damage the stomach or duodenal lining.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):
  • Chronic use of NSAIDs, including aspirin, ibuprofen, and naproxen, is a significant risk factor for developing peptic ulcers.
  • NSAIDs inhibit the production of prostaglandins, reducing the protective mucosal layer and increasing vulnerability to injury.
• Gastric Acid Hypersecretion:
  • Conditions associated with increased gastric acid production, such as Zollinger-Ellison syndrome, can lead to the development of peptic ulcers.
  • Excessive acid production contributes to mucosal erosion and ulceration.
• Smoking and Alcohol Consumption:
  • Smoking and heavy alcohol consumption are considered risk factors for peptic ulcers.
  • These behaviors may compromise the protective mechanisms of the gastrointestinal mucosa.
• Genetic Factors:
  • Genetic predisposition may play a role in an individual’s susceptibility to peptic ulcers.
  • Some people may have a familial tendency toward developing ulcers, suggesting a genetic influence on susceptibility.
• Helicobacter pylori Infection:
  • Infection with Helicobacter pylori, a bacterium, is a major cause of peptic ulcers.
  • H. pylori colonizes the stomach lining and produces substances that weaken the mucosal defense, making it more susceptible to damage from gastric acid.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):
  • Chronic use of NSAIDs, such as aspirin and ibuprofen, can contribute to the development of peptic ulcers.
  • NSAIDs inhibit prostaglandin synthesis, reducing the protective mucosal layer and increasing susceptibility to injury.

Desired Outcomes for the Management of Peptic Ulcer Disease (PUD)

• Ulcer Healing and Symptom Resolution:
  • Resolution of peptic ulcers through effective treatment, leading to the healing of mucosal lesions.
  • Relief from symptoms such as epigastric pain, nausea, and gastrointestinal discomfort.
• Eradication of Helicobacter pylori:
  • Successful eradication of Helicobacter pylori infection through antibiotic therapy.
  • Reduction in the risk of recurrent peptic ulcers associated with H. pylori.
• Prevention of Recurrence:
  • Implementation of preventive measures to reduce the risk of ulcer recurrence.
  • Lifestyle modifications, such as dietary changes and avoidance of NSAIDs, to promote long-term gastrointestinal health.
• Management of Complications:
  • Prevention and management of complications associated with PUD, such as gastrointestinal bleeding or perforation.
  • Timely intervention to address any complications and minimize their impact on the patient’s health.
• Patient Education and Adherence:
  • Patient understanding of the importance of medication adherence, particularly for antibiotics, proton pump inhibitors (PPIs), and other prescribed medications.
  • Education on lifestyle modifications, including dietary choices and stress management, to support long-term ulcer prevention.

Peptic Ulcer Disease (PUD) Nursing Care Plan

Nursing Interventions and Rationales

• Assess and Monitor vitals

• Perform detailed pain assessment

• Evaluate lab test

• Prepare patient for and assist with upper GI Endoscopy

• Administer medications as ordered

• Nutrition Education

• Encourage lifestyle changes

Nursing Evaluation in the Context of Managing Peptic Ulcer Disease (PUD)

• Symptom Relief:
  • Assess for resolution or reduction of symptoms, such as epigastric pain, nausea, and gastrointestinal discomfort.
  • Utilize patient reports and observation to determine the effectiveness of prescribed medications and interventions.
• Helicobacter pylori Eradication:
  • Confirm the success of Helicobacter pylori eradication through follow-up testing.
  • Evaluate the patient’s adherence to the antibiotic regimen and address any concerns or barriers to completion.
• Medication Adherence:
  • Assess the patient’s adherence to prescribed medications, including proton pump inhibitors, H2-receptor antagonists, and other medications.
  • Identify and address any challenges or side effects that may impact adherence.
• Dietary and Lifestyle Changes:
  • Evaluate the patient’s adoption of recommended dietary modifications and lifestyle changes.
  • Encourage a follow-up discussion to address any difficulties or barriers in implementing these modifications.
• Prevention of Recurrence:
  • Monitor for signs of recurrent ulcers or complications.
  • Assess the patient’s understanding of and adherence to long-term preventive measures, including dietary choices, medication compliance, and lifestyle modifications.

References

• https://www.mayoclinic.org/diseases-conditions/peptic-ulcer/diagnosis-treatment/drc-20354229
• https://emedicine.medscape.com/article/181753-clinical
• https://www.webmd.com/digestive-disorders/peptic-ulcer-overview#1
• https://online.epocrates.com/diseases/80/Peptic-ulcer-disease